Insights Into Ovarian Cancer

Perspectives on current treatment practices in the management of ovarian cancer with regard to molecular testing and first-line and maintenance therapy options

East Coast – July 27, 2021
Purchase Report

Faculty Chair

Thomas Herzog, MD

University of Cincinnati Cancer Center, Cincinnati, OH

Midwest – September 8, 2021
Purchase Report

Faculty Chair

Robert Coleman, MD

MD Anderson Cancer Center, Houston, TX

More Information

  • Virtual Series
  • East Coast

More Information

  • Virtual Series
  • Illinois, Iowa, Nebraska, North Dakota, South Dakota, Minnesota, Wisconsin, Michigan, Indiana, Ohio

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of ovarian cancer
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies were obtained: chemotherapies (platinums, taxanes), olaparib, niraparib, bevacizumab

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprised 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.